Drug Database
Back to search

Netherlands· NL-73862b6ab8a7

GRAZAX, lyofilisaat voor oraal gebruik 75.000 SQ-T

A gräserpollen product containing timotheegraspollenextract "alk", registered in Netherlands by Originalis B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC V01AA02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedGRAZAX, lyofilisaat voor oraal gebrui…ATCV01AA02REGISTER NO.NL-73862b6ab8a7PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about timotheegraspollenextract "alk"Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Gräserpollen is registered in 11 of 19 countries.

Countries holding a registration under ATC V01AA02 (gräserpollen), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search gräserpollen products by name

Gräserpollen · ATC V01AA02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TIMOTHEEGRASPOLLENEXTRACT "ALK"
Manufacturer
Originalis B.V.
Country
Netherlands (NL)
ATC code
V01AA02
ATC class
Gräserpollen
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    128154//33788

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under V01AA02

Gräserpollen, as other registers publish it.

All gräserpollen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c53656ee-605c-4f02-9cfb-2614e7907a4d
GET /v1/drugs/c53656ee-605c-4f02-9cfb-2614e7907a4d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Lyofilisaat voor oraal gebruik",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h33788_smpc.pdf",
  "strength": null,
  "atc_label": "Grass Pollen",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg128154",
  "excipients": [
    "GELATINE, AFKOMSTIG VAN VIS",
    "MANNITOL (D-) (E 421)",
    "NATRIUMHYDROXIDE (E 524)"
  ],
  "substances": [
    "TIMOTHEEGRASPOLLENEXTRACT \"ALK\""
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h128154.pdf",
  "authorised_at": "2021/05/19",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "128154//33788",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about gräserpollen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console